P

Inventor

FORTIN JÉRÔME MICHEL CLAUDE

FR11 patents
⚠️ This page may combine multiple inventors who share the name “FORTIN JÉRÔME MICHEL CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN SCIENCES IRELAND UNLIMITED CO

4 patents
US11702426B2Jul 18, 2023

Macrocyclic deaza-purinones for the treatment of viral infections

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations61
US11104678B2Aug 31, 2021

Purine derivatives for the treatment of viral infections

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations61
US10829494B2Nov 10, 2020

Macrocyclic deaza-purinones for the treatment of viral infections

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations51
US10822349B2Nov 3, 2020

Macrocyclic purines for the treatment of viral infections

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations50

JANSSEN SCIENCES IRELAND UC

2 patents
US10280167B2May 7, 2019

Purine derivatives for the treatment of viral infections

JANSSEN SCIENCES IRELAND UC1 citations72
US10266543B2Apr 23, 2019

Macrocyclic deaza-purinones for the treatment of viral infections

JANSSEN SCIENCES IRELAND UC2 citations71

JANSSEN PHARMACEUTICALS INC

2 patents
US11795149B2Oct 24, 2023

Substituted indoline derivatives as dengue viral replication inhibitors

JANSSEN PHARMACEUTICALS INC0 citations61
US11407715B2Aug 9, 2022

Substituted indoline derivatives as dengue viral replication inhibitors

JANSSEN PHARMACEUTICALS INC0 citations61

JANSSEN R&D IRELAND

1 patent
US9556176B2Jan 31, 2017

Purine derivatives for the treatment of viral infections

JANSSEN R&D IRELAND29 citations93

JANSSEN BIOPHARMA INC

1 patent
US11312727B1Apr 26, 2022

Macrocyclic flu endonuclease inhibitors

JANSSEN BIOPHARMA INC0 citations50

BONFANTI JEAN-FRANCOIS

1 patent
US8883837B2Nov 11, 2014

Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

BONFANTI JEAN-FRANCOIS0 citations44